Back to Agenda
Navigating the FDA Commissioner's National Priority Voucher Program: Implementation Insights and Strategic Impact
Session Chair(s)
Lina AlJuburi, PHARMD, MSC
Head, Regulatory Science and Policy, North America
Sanofi, United States
The FDA Commissioner's National Priority Voucher (CNPV) program represents a novel regulatory mechanism designed to accelerate the development and review of drugs addressing critical public health priorities. This session provides a comprehensive analysis
Learning Objective : Discuss the fundamental framework and eligibility criteria of the CNPV program; Analyze real implementation challenges and successful strategies; Evaluate the program's impact on expediting critical drug development and public health priorities.
Speaker(s)
Panelist
Representative Invited
FDA, United States
Panelist
Lawrence Liberti, PHD, RAC
The Kim Center/ USC DRQS, United States
Director, D.K. Kim International Center for Regulatory Science
Panelist
Kellie Taylor
VP, CMC Regulatory Affairs, United States
VP, CMC Regulatory Affairs
Panelist
Elizabeth Lange, MPH, MS
XX, United States
VP & Head of Global Regulatory Science, Policy and Intelligence
Have an account?